Recurrent pneumococcal bacteremia: Risk factors and outcomes

Archives of Internal Medicine

Volumn 161, Issue 17, 2001, Pages 2141-2144

  Turett, Glenn S ^a   Blum, Steve ^b   Telzak, Edward E ^b  

^a ST VINCENT S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BACTEREMIA; CANCER; CONTROLLED STUDY; DISEASE SEVERITY; ETHNOLOGY; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; RISK FACTOR; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; RECURRENCE; RISK FACTORS; SURVIVAL RATE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0035944372     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.17.2141     Document Type: Article

References (25)

1. Matter L, Wilhelm JA, Angehrn W, Skvaril F, Schopfer K. Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Siogren's syndrome, hyperimmunoglobulinemia G, and deficiencies of Ig62 and Ig64. N Engl J Med. 1985;312:1039-1042.
2. Gelfand EW, Rao CP, Minta JO, Ham T, Purkall DB, Ruddy S. Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia. Am J Med. 1987;82:671-675.
3. Lee W, Austrian R, Weiser JN. Recurrent pneumococcal bacteremia in normal children. Pediatr Infect Dis J. 1994;13:231-233.
4. Kuhls TL, Viering TP, Leach CT, Steele MI, Haglund LA, Fine DP. Relapsing pneumococcal bacteremia in immunocompromised patients. Clin Infect Dis. 1992;14:1050-1054.
5. Gransden WR, Eykyn SJ. Recurrent pneumococcal bacteremia. Clin Infect Dis. 1992;15:1072-1073.
6. Rodriguez-Creixems M, Munoz P, Miranda E, Pelaez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia: a warning of immunodeficiency. Arch Intern Med. 1996;156:1429-1434.
7. Coccia MR, Facklam RR, Saravolatz LD, Manzor O. Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis. 1998;26:982-985.
8. Simberkoff MS, Sadr WE, Schiffmen G, Rahal JJ. Streptococcus pneumoniae infections and bacteremia in patients with acquired immunodeficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis. 1984;130:1174-1176.
9. Polsky B, Gold JWM, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986;104:38-41.
10. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Med. 1987;82:900-906.
11. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990;162:1012-1017.
12. Rodriguez-Barradas MC, Musher DM, Hamill RJ, Dowell M, Bagwell JT, Sanders CV. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis. 1992;14:192-199.
13. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis. 1993;167:49-56.
14. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 1995;333:845-851.
15. Garcia-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vicente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients with the human immunodeficiency virus. Arch Intern Med. 1992;152:1808-1812.
16. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA. 1996;275:194-198.
17. Frankel RE, Virata M, Hardalo C, et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis. 1996;23:577-584.
18. Gilks CF, Ojoo SA, Ojoo JC, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996;347:718-723.
19. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between H IV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182-190.
20. Ernst J, Amaral L, Janseen R. Seroprevalence rates of HIV infection at Bronx-Lebanon Hospital Center, 1988-1991. In: Program and abstracts of the 8th International Conference on AIDS; 1992; Amsterdam, the Netherlands.
21. Turett G, Blum S, Fazal B, Justman J, Telzak E. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence. Clin Infect Dis. 1999;29:321-327.
22. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing, Sixth Informational Supplement (M100-S6). Villanova, Pa: National Committee for Clinical Laboratory Standards; 1995.
23. Meynard JL, Barbut F, Blum L, et al. Risk factors for isolation of Streptococcus pneumoniaewith decreased susceptibility to penicillin from patients infected with human immunodeficiency virus. Clin Infect Dis. 1996;22:437-440.
24. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis. 1994;19:884-890.
25. Pallares R, Gudiol F, Linares J, et al. Riskfactors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317:18-22.